Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (81-90 of 328) with videos related to

Pageof 33
Sort By:
International Journal of Hematology|February 27, 2021
A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myelomaShinsuke Iida, Kazutaka Sunami, Hironobu Minami, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|August 9, 2019
Plasma cell myeloma positive for t(14;20) with relapse in the central nervous systemTakayuki Murase, Atsushi Inagaki, Ayako Masaki, et al.
International Journal of Cancer|February 6, 2007
Regulatory T-cell function of adult T-cell leukemia/lymphoma cellsHiroki Yano, Takashi Ishida, Atsushi Inagaki, et al.
International Journal of Hematology|July 19, 2022
A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1)Kentaro Hirade, Shigeru Kusumoto, Akihiro Abe, et al.
Japanese Journal of Clinical Oncology|August 12, 2020
Factors associated with suicidal ideation in patients with multiple myelomaTatsuo Akechi, Toru Okuyama, Megumi Uchida, et al.
Cancer Science|August 25, 2019
Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myelomaKeiko Maekawa, Masaki Ri, Miki Nakajima, et al.
International Journal of Hematology|August 19, 2025
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 2. Related disorders of multiple myelomaShinsuke Iida, Shigeki Ito, Kazutaka Sunami, et al.
Cancer Science|January 6, 2011
Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myelomaSandra Grass, Shinsuke Iida, Aleksandra Wikowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecifiedTakashi Ishida, Hiroshi Inagaki, Atae Utsunomiya, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with PazopanibYoshinori Mori, Shiori Kinoshita, Takashi Kanamori, et al.
Pageof 33

Showing results (81-90 of 328) with videos related to

Sort By:
Pageof 33
International Journal of Hematology|February 27, 2021
A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myelomaShinsuke Iida, Kazutaka Sunami, Hironobu Minami, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|August 9, 2019
Plasma cell myeloma positive for t(14;20) with relapse in the central nervous systemTakayuki Murase, Atsushi Inagaki, Ayako Masaki, et al.
International Journal of Cancer|February 6, 2007
Regulatory T-cell function of adult T-cell leukemia/lymphoma cellsHiroki Yano, Takashi Ishida, Atsushi Inagaki, et al.
International Journal of Hematology|July 19, 2022
A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1)Kentaro Hirade, Shigeru Kusumoto, Akihiro Abe, et al.
Japanese Journal of Clinical Oncology|August 12, 2020
Factors associated with suicidal ideation in patients with multiple myelomaTatsuo Akechi, Toru Okuyama, Megumi Uchida, et al.
Cancer Science|August 25, 2019
Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myelomaKeiko Maekawa, Masaki Ri, Miki Nakajima, et al.
International Journal of Hematology|August 19, 2025
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 2. Related disorders of multiple myelomaShinsuke Iida, Shigeki Ito, Kazutaka Sunami, et al.
Cancer Science|January 6, 2011
Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myelomaSandra Grass, Shinsuke Iida, Aleksandra Wikowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecifiedTakashi Ishida, Hiroshi Inagaki, Atae Utsunomiya, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with PazopanibYoshinori Mori, Shiori Kinoshita, Takashi Kanamori, et al.
Pageof 33